Endocrinology, Oncology

Diabetes Drug Shows Promise in Slowing Prostate Cancer, Study Finds

/

Research suggests Pioglitazone, a diabetes drug, may inhibit prostate cancer by altering cell metabolism and reducing tumor growth.